Researchers sought to determine the humoral immune response to the COVID-19 vaccine in patients with cancer after a third or fourth dose of the vaccine or breakthrough infection.
Artificial intelligence can predict survival in cancer patients using information from a patient’s initial consultation with an oncologist, a study suggests.